Imderma Pharma Private Limited
About Imderma Pharma Private Limited
Data last updated:
Imderma Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the household goods segment of the home appliances and consumer durables sector. It was incorporated on 10 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2021PTC355060.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Swati Katre and Sagar Umbarkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 304 Morganite Shiv Brighton 2 Nagpur (Rural), Maharashtra, India – 441108.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.63 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹3.03 Lakh (net margin 1.9%) and EBITDA of ₹7.09 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 131% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address304 Morganite Shiv Brighton 2 Nagpur (Rural), Maharashtra, India – 441108
- IndustryHome Appliances, Household Goods, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Imderma Pharma Private Limited
The main business activity of Imderma Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Imderma Pharma Private Limited FY 2025 filings available
Imderma Pharma Private Limited reported revenue of ₹1.63 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Imderma Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 131% over three years, including 3% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Imderma Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.09 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.03 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Imderma Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Imderma Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Imderma Pharma Private Limited
Imderma Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VSM Advance Automation Private Limited | ₹1.63 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | New Delhi, Delhi, India |
| Fifth Avenue Gems Private Limited | ₹1.63 Cr (FY 2025) | •••• | •••• | 3929.0% | •••• | Mumbai, Maharashtra, India |
| Sawan Ishwar Optic Care Private Limited | ₹1.63 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | New Delhi, Delhi, India |
| Vnmetrix Pharma Specialities Private Limited | ₹1.63 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Pune, Maharashtra, India |
| Corbis Opticals Private Limited | ₹1.63 Cr (FY 2025) | •••• | •••• | 92.0% | •••• | Ernakulam, Kerala, India |
| Imderma Pharma Private Limited this company | ₹1.63 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Nagpur, Maharashtra, India |
| Grabnlifters Private Limited | ₹1.63 Cr (FY 2025) | •••• | •••• | 312.0% | •••• | Hyderabad, Telangana, India |
| Pro Edge Fitness Private Limited | ₹1.62 Cr (FY 2025) | •••• | •••• | 487.0% | •••• | Kolkata, West Bengal, India |
| V4m Retail Private Limited | ₹1.62 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Delhi, India |
| Silvertoss Vanijya Private Limited | ₹1.62 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Mumbai, Maharashtra, India |
| Shrilekha Trading Private Limited | ₹1.62 Cr (FY 2025) | •••• | •••• | -28.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Imderma Pharma by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Imderma Pharma Private Limited
Imderma Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swati Katre | Director | 10 Feb 2021 | 5 Years 8 Months | Current |
| Sagar Umbarkar | Director | 15 Nov 2025 | 0 Years 11 Months | Current |
Charges & Borrowings of Imderma Pharma Private Limited
Imderma Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Imderma Pharma Private Limited
Employment history and EPFO contributions of people linked to Imderma Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Imderma Pharma Private Limited
Imderma Pharma Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Kalpana Umbarkar ceased to be Director on 15 Nov 2025.
Credit Ratings, Litigation & Regulatory Alerts for Imderma Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Imderma Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Imderma Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Imderma Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Imderma Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imderma Pharma Private Limited
Imderma Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in household goods, within the home appliances industry. It was incorporated on 10 February 2021 (5+ years old) and is registered under CIN U51397MH2021PTC355060.
Imderma Pharma reported revenue of ₹1.63 Cr for FY 2025 (up 3% YoY).
Imderma Pharma has 2 current directors:
- Swati Katre - Director
- Sagar Umbarkar - Director
Imderma Pharma reported a net profit of ₹3.03 Lakh (net margin 1.9%) and EBITDA of ₹7.09 Lakh (EBITDA margin 4.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Imderma Pharma is 131% over three years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Imderma Pharma is U51397MH2021PTC355060. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Imderma Pharma was incorporated on 10 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Imderma Pharma by revenue are VSM Advance Automation Private Limited, Fifth Avenue Gems Private Limited, Sawan Ishwar Optic Care Private Limited, Vnmetrix Pharma Specialities Private Limited, Corbis Opticals Private Limited and 5 more, all in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles).
Kalpana Umbarkar ceased to be Director on 15 Nov 2025. Sagar Umbarkar was appointed as Director on 15 Nov 2025. Kalpana Umbarkar was appointed as Director on 10 Feb 2021. Imderma Pharma has 4 board changes on record in total.
The registered office of Imderma Pharma is at 304 Morganite Shiv Brighton 2 Nagpur Rural, Maharashtra, India – 441108.
Imderma Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh.